Clinical observations of creatine phosphate cardioplegia on myocardial protection

胡克俭,叶磊,贺伯民,庄杏妹,刘祖谮,王春生,蒋振斌
DOI: https://doi.org/10.3969/j.issn.0253-9934.2001.07.008
2001-01-01
Abstract:Objective To observe the protective mechanism of creatine phosphate cardioplegia on the myocardium. Method 16 patients were divided into two groups (n=8 respectively):control group (C group) and experimental group (E group). Blood concentrations of the lactic acid (LA), malonyldialdehyde (MDA), superoxide dismuutase (SOD) and xanthine oxidase (XOD) were measured before aortic clamping and 5,15,30,60,120 minutes after release of aortic clamping, cardiac tropomin T (cTnT) wasmeasured before aortic clamping and 2,24,48hours after release of aortic clamping. Just after aortic clamping and before releasing aortic clamping; samples were taken from left atrium and examined under electronmicroscope. Results 5,15,30minutes after releasing aortic clamping the concentrations of LA, MDA in group E were lower than those in group C ( P 0.05, 0.01 respectively); elevation of SOD was higher than that in group C ( P 0.05); there was no difference in XOD between the two groups. 2,24,48 hours after releasing the aortic clamping, the values of cTnT in group E were lower than those in group C ( P 0.01). Electronmicroscopy showed that the mitochondria in group E were better than that in the group C 1.872±0.524 vs 2.725± 0.832 ( P 0.001). Conclusion CP can provide energy for myocardial cells, protect the cell membrane integrity and maintain the normal action of contractile protein. It also shows that CP can relieve the ischemia/reperfusion injury.
What problem does this paper attempt to address?